nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anticoagulation and antiplatelet therapy in stable coronary artery disease: A multicenter survey
|
Kopin, David |
|
2019 |
180 |
C |
p. 25-27 |
artikel |
2 |
Atherosclerosis, myocardial infarction and primary hemostasis: Impact of platelets, von Willebrand factor and soluble glycoprotein VI
|
Villmann, Josepha-Maria |
|
2019 |
180 |
C |
p. 98-104 |
artikel |
3 |
Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen
|
Moret, Andrés |
|
2019 |
180 |
C |
p. 115-117 |
artikel |
4 |
Cost effectiveness analysis of direct oral anticoagulant (DOAC) versus dalteparin for the treatment of cancer associated thrombosis (CAT) in the United States
|
Li, Ang |
|
2019 |
180 |
C |
p. 37-42 |
artikel |
5 |
Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia – Need for a higher than recommended weight-based dosing
|
Castelino, Ronald L. |
|
2019 |
180 |
C |
p. 70-73 |
artikel |
6 |
Differences between metabolically healthy and unhealthy obesity in PAI-1 level
|
Basurto, Lourdes |
|
2019 |
180 |
C |
p. 110-114 |
artikel |
7 |
Editorial Board
|
|
|
2019 |
180 |
C |
p. IFC |
artikel |
8 |
Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia
|
Althaus, Karina |
|
2019 |
180 |
C |
p. 55-61 |
artikel |
9 |
Excessive expressions of T cell activation markers in pediatric immune thrombocytopenia
|
Chen, Yuanyuan |
|
2019 |
180 |
C |
p. 1-9 |
artikel |
10 |
Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin
|
Barale, Cristina |
|
2019 |
180 |
C |
p. 74-85 |
artikel |
11 |
Influence of genetic polymorphisms in DICER and XPO5 genes on the risk of coronary artery disease and circulating levels of vascular miRNAs
|
Borghini, Andrea |
|
2019 |
180 |
C |
p. 32-36 |
artikel |
12 |
It's time for head-to-head trials with direct oral anticoagulants
|
Tritschler, Tobias |
|
2019 |
180 |
C |
p. 64-69 |
artikel |
13 |
Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next?
|
Rodger, Marc A. |
|
2019 |
180 |
C |
p. 105-109 |
artikel |
14 |
Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa
|
Favaloro, Emmanuel J. |
|
2019 |
180 |
C |
p. 10-19 |
artikel |
15 |
Neutrophil extracellular traps induced by activated platelets contribute to procoagulant activity in patients with colorectal cancer
|
Zhang, Yan |
|
2019 |
180 |
C |
p. 87-97 |
artikel |
16 |
Outcomes associated with a change in clinical practice to alleviate emotional harm related to venous thromboembolism
|
Jones, Aubrey E. |
|
2019 |
180 |
C |
p. 29-31 |
artikel |
17 |
Predictive value of the present-on-admission indicator for hospital-associated hemorrhage
|
Ghazvinian, Roxanne |
|
2019 |
180 |
C |
p. 20-24 |
artikel |
18 |
Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding
|
Little, Derek |
|
2019 |
180 |
C |
p. 86 |
artikel |
19 |
The efficacy and safety of anticoagulation in cerebral vein thrombosis: A Systematic review and meta-analysis
|
Al Rawahi, Bader |
|
2019 |
180 |
C |
p. 28 |
artikel |
20 |
The prognostic value of multiple electrode aggregometry and light transmittance aggregometry in stable cardiovascular patients with type 2 diabetes mellitus
|
Tsantes, Argirios Ε. |
|
2019 |
180 |
C |
p. 47-54 |
artikel |
21 |
Thromboprophylaxis by rivaroxaban, aspirin, both, or placebo after hospitalization for medical illness
|
Tomkowski, Witold Z. |
|
2019 |
180 |
C |
p. 62-63 |
artikel |
22 |
Use of direct oral anticoagulants prevents increase in pulmonary vascular resistance and incidence of clinical worsening in patients with chronic thromboembolic pulmonary hypertension
|
Hosokawa, Kazuya |
|
2019 |
180 |
C |
p. 43-46 |
artikel |